Chat with Filing

Ask questions about this document

Please log in or register to use the chat feature. Please register first.

RNS - OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meetin

Company: OPKO Health Inc. Date: 2025-06-25 Language: English Register to download

Loading document preview...

Document Preview Not Available

The file type (.htm) cannot be displayed directly here.

Open Original File

Error loading document preview. Please try the 'Open Original File' link.

You're One Click Away From The Full Filing

Instantly access this document—and 2.8M more—for free. Select your preferred method:

Continue with Google Continue with Microsoft Continue with Facebook Continue with Amazon

   

���� ���� 2025, ����� ����� ����� ����� ������ ����������� ����������� �� ����� ������� ������ ������ ��� ������� ��������. false

|     |     |
| --- | --- |
| ����� ���', ���� | 2 380 |
| OPKO HEALTH, INC |
| Corporation no: 2279206 | 13156 |
| - - - |
|     |

|     |     |     |     |     |     |     |     |     |     |     |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|     | Israel Securities Authority |     |     | Tel Aviv Stock Exchange |     | C002 ( Public ) |     | Reported via MAGNA: | 25/06/2025 |     |
|     | www.isa.gov.il |     |     | www.tase.co.il |     |     |     | Reference: | 2025-02-045450 | Time of broadcast: 15:52 15:52 |

- - -

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000  

  

|     |     |
| --- | --- |
|     | The corporation is a foreign private issuer as defined by U.S. Securities Laws. |

  

Attached hereto is a report on*���� ���� 2025, ����� ����� ����� ����� ������ ����������� ����������� �� ����� ������� ������ ������ ��� ������� ��������.*  

*20250625\_PR\_Entera\_ENDO\_OXM\_Abstract\_Selection\_isa.pdf*

|     |     |
| --- | --- |
|     |     |
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): |     |
|     |     |
|     |     |
| - - - |     |
| Stock Exchange/Market: NASDAQ GSM | Date of revision of form structure: 06/08/2024 |
| Address: Ashlegan 16 , Kiryat Gat 8211804   Israel , Tel: 08-9300051 , Fax: 08-9543101 |     |
| E-mail address: gfaibish@opko.com   Company site: Www.Opko.Com |     |
|     |     |
| Previous names of reporting entity: |     |
|     |     |
| Name of the Signatory: Faibish Gabriel Position of Signatory in the reporting corporation: General Counsel Name of Employer Company: |     |
| Address: Ashlegan 16 , Kiryat Gat 8211804 Telephone: 08-9300051 Facsimile: 08-9543101 E-mail: gfaibish@opko.com 1 |     |
|     |